ATE490782T1 - Chimäre vakzine-antigene gegen das klassische schweinefieber-virus - Google Patents
Chimäre vakzine-antigene gegen das klassische schweinefieber-virusInfo
- Publication number
- ATE490782T1 ATE490782T1 AT07711102T AT07711102T ATE490782T1 AT E490782 T1 ATE490782 T1 AT E490782T1 AT 07711102 T AT07711102 T AT 07711102T AT 07711102 T AT07711102 T AT 07711102T AT E490782 T1 ATE490782 T1 AT E490782T1
- Authority
- AT
- Austria
- Prior art keywords
- fever virus
- swine fever
- vaccine antigens
- antigens against
- chimeric vaccine
- Prior art date
Links
- 241000710777 Classical swine fever virus Species 0.000 title 1
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/18—Togaviridae; Flaviviridae
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/01—Animal expressing industrially exogenous proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Treatment Of Fiber Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CU20060052A CU23544A1 (es) | 2006-02-28 | 2006-02-28 | Antígenos vacunales quiméricos contra el virus de la peste porcina clásica |
PCT/CU2007/000008 WO2007098717A2 (es) | 2006-02-28 | 2007-02-28 | Antígenos vacunales quiméricos contra el virus de la peste porcina clásica |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE490782T1 true ATE490782T1 (de) | 2010-12-15 |
Family
ID=38279009
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT07711102T ATE490782T1 (de) | 2006-02-28 | 2007-02-28 | Chimäre vakzine-antigene gegen das klassische schweinefieber-virus |
Country Status (17)
Country | Link |
---|---|
US (1) | US8409562B2 (de) |
EP (1) | EP1994943B1 (de) |
JP (1) | JP5190383B2 (de) |
KR (1) | KR101506979B1 (de) |
CN (2) | CN105214081A (de) |
AR (1) | AR059648A1 (de) |
AT (1) | ATE490782T1 (de) |
BR (1) | BRPI0708354B1 (de) |
CA (1) | CA2638830C (de) |
CL (1) | CL2007000529A1 (de) |
CU (1) | CU23544A1 (de) |
DE (1) | DE602007011042D1 (de) |
ES (1) | ES2357563T3 (de) |
HK (1) | HK1219052A1 (de) |
MX (1) | MX2008011144A (de) |
RU (1) | RU2406534C2 (de) |
WO (1) | WO2007098717A2 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI362416B (en) * | 2008-07-31 | 2012-04-21 | Mao Xing Biolog Technology Co Ltd | Yeast expressed classical swine fever virus glycoprotein e2 and use thereof |
WO2010111687A2 (en) | 2009-03-27 | 2010-09-30 | Academia Sinica | Methods and compositions for immunization against virus |
CN109563518A (zh) * | 2016-05-12 | 2019-04-02 | 巴伊沃爱普有限公司 | 来自植物的用于经典猪瘟的疫苗组合物及其制造方法 |
KR20210149121A (ko) * | 2019-04-25 | 2021-12-08 | 애그리컬쳐럴 테크놀로지 리서치 인스티튜트 | 돼지열병 바이러스 감염 예방용 재조합 단백질 및 이를 포함하는 조성물과 세포 |
CU20210070A7 (es) * | 2021-08-20 | 2023-03-07 | Ct Ingenieria Genetica Biotecnologia | Antígenos quiméricos para el control de coronavirus y composiciones que los comprenden |
CN114835822B (zh) * | 2022-04-22 | 2022-11-04 | 浙江洪晟生物科技股份有限公司 | 猪瘟病毒的多聚体疫苗及其制备方法 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4542225A (en) * | 1984-08-29 | 1985-09-17 | Dana-Farber Cancer Institute, Inc. | Acid-cleavable compound |
ZA901719B (en) | 1989-03-19 | 1991-01-30 | Akzo Nv | Hog cholera virus vaccine and diagnostics |
US5651972A (en) | 1989-04-21 | 1997-07-29 | University Of Florida Research Foundation, Inc. | Use of recombinant swine poxvirus as a live vaccine vector |
EP0924298A1 (de) | 1997-12-18 | 1999-06-23 | Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) | Proteinexpression in Baculovirus-vektor Expressionsystemen |
FR2804028B1 (fr) | 2000-01-21 | 2004-06-04 | Merial Sas | Vaccins adn ameliores pour animaux de rente |
CA2413265A1 (en) | 2000-05-03 | 2001-11-08 | University Of Guelph | Porcine adenovirus type 5 vector and vaccine |
RU2183972C2 (ru) | 2000-07-13 | 2002-06-27 | ВНИИ ветеринарной вирусологии и микробиологии | Способ получения высокоактивной специфической к вирусу классической чумы свиней сыворотки крови свиней |
CN1338309A (zh) | 2000-08-10 | 2002-03-06 | 清华大学 | 一种合成肽猪瘟疫苗及其制备方法 |
RU2182495C1 (ru) | 2001-05-03 | 2002-05-20 | Федеральное государственное учреждение Всероссийский научно-исследовательский институт защиты животных | Вирусвакцина против классической чумы свиней |
US20040096457A1 (en) * | 2001-12-11 | 2004-05-20 | Huber Brigitte T | Treatment and prevention of ebv infection and ebv-associated disorders |
CU23102A1 (es) * | 2002-10-21 | 2005-12-20 | Ct Ingenieria Genetica Biotech | Método para la producción de proteínas recombinantes en la glándula mamaria de mamíferos no transgénicos |
US7183384B2 (en) * | 2003-03-06 | 2007-02-27 | A & G Pharmaceutical, Inc. | Monoclonal antibody 7H11 reactive with human cancer |
EP1522585A1 (de) * | 2003-10-09 | 2005-04-13 | Plant Research International B.V. | Chimäre Trägermoleküle zur Produktion von Impfstoffen, die durch die Schleimhaut aufgenommen werden |
-
2006
- 2006-02-28 CU CU20060052A patent/CU23544A1/es active IP Right Grant
-
2007
- 2007-02-27 AR ARP070100808A patent/AR059648A1/es active IP Right Grant
- 2007-02-27 CL CL2007000529A patent/CL2007000529A1/es unknown
- 2007-02-28 DE DE602007011042T patent/DE602007011042D1/de active Active
- 2007-02-28 AT AT07711102T patent/ATE490782T1/de not_active IP Right Cessation
- 2007-02-28 CA CA2638830A patent/CA2638830C/en active Active
- 2007-02-28 CN CN201510530087.8A patent/CN105214081A/zh active Pending
- 2007-02-28 KR KR1020087023580A patent/KR101506979B1/ko active IP Right Grant
- 2007-02-28 ES ES07711102T patent/ES2357563T3/es active Active
- 2007-02-28 US US12/280,055 patent/US8409562B2/en active Active
- 2007-02-28 MX MX2008011144A patent/MX2008011144A/es active IP Right Grant
- 2007-02-28 BR BRPI0708354A patent/BRPI0708354B1/pt active IP Right Grant
- 2007-02-28 JP JP2008556644A patent/JP5190383B2/ja active Active
- 2007-02-28 WO PCT/CU2007/000008 patent/WO2007098717A2/es active Search and Examination
- 2007-02-28 CN CNA2007800146285A patent/CN101426525A/zh active Pending
- 2007-02-28 RU RU2008138536/10A patent/RU2406534C2/ru active
- 2007-02-28 EP EP07711102A patent/EP1994943B1/de active Active
-
2016
- 2016-06-21 HK HK16107128.2A patent/HK1219052A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
EP1994943B1 (de) | 2010-12-08 |
CN105214081A (zh) | 2016-01-06 |
CU23544A1 (es) | 2010-06-17 |
WO2007098717A2 (es) | 2007-09-07 |
CA2638830A1 (en) | 2007-09-07 |
JP2009528304A (ja) | 2009-08-06 |
ES2357563T3 (es) | 2011-04-27 |
BRPI0708354A2 (pt) | 2011-05-24 |
MX2008011144A (es) | 2009-01-26 |
RU2008138536A (ru) | 2010-04-10 |
DE602007011042D1 (de) | 2011-01-20 |
HK1219052A1 (zh) | 2017-03-24 |
US8409562B2 (en) | 2013-04-02 |
JP5190383B2 (ja) | 2013-04-24 |
CA2638830C (en) | 2015-04-14 |
CN101426525A (zh) | 2009-05-06 |
US20090304633A1 (en) | 2009-12-10 |
RU2406534C2 (ru) | 2010-12-20 |
WO2007098717A3 (es) | 2007-11-01 |
EP1994943A2 (de) | 2008-11-26 |
CL2007000529A1 (es) | 2008-01-18 |
AR059648A1 (es) | 2008-04-16 |
KR101506979B1 (ko) | 2015-03-30 |
BRPI0708354B1 (pt) | 2016-04-19 |
KR20080111023A (ko) | 2008-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1959991T3 (da) | Terapeutisk vaccine | |
DK1968631T3 (da) | Vaccine | |
DK1957528T3 (da) | Nukleotid-vaccine | |
DK2481420T3 (da) | Enkeltdosis-anti-PCV2-svinevaccine | |
ATE462445T1 (de) | Prrs-impfstoffe | |
DK2049559T3 (da) | Forbedrede HPV vacciner | |
ATE450271T1 (de) | Impfstoff | |
DK1858917T3 (da) | Varicella-zoster-virus-vaccine | |
DK2200646T3 (da) | RNA-Vacciner | |
DK1926496T3 (da) | PCV-2-vaccine | |
ZA200810285B (en) | A novel virulence determinant within the E2 structural glycoproptein of Classical Swine Fever Virus | |
MA28609B1 (fr) | Vaccins | |
DK2114993T3 (da) | Vaccine | |
DK1991564T3 (da) | Virosomlignende vesikler omfattende gp41-afledte antigener | |
BRPI0813892A2 (pt) | composições que compreendem antígenos pneumococcal | |
MA28639B1 (fr) | Vaccins | |
EP2062246A4 (de) | Impfstoffe gegen chimärische viren | |
HK1219052A1 (zh) | 針對典型性豬瘟病毒的嵌合疫苗抗原 | |
DE602005008726D1 (de) | Verwendet | |
DK1751276T3 (da) | Vaccine omfattende en svækket pestvirus | |
BRPI0917205A2 (pt) | vacina polivalente | |
DK2043682T3 (da) | Influenzavaccine | |
ATE432082T1 (de) | Impfstoff gegen periodontale krankheit | |
BRPI0811021A2 (pt) | Peptídeos e vacinas de tem8 compreendendo os mesmos | |
MA28885B1 (fr) | vaccins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |